Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Corporate Profile

Enzo Biochem Inc.

Enzo Biochem, Inc., a public corporation listed on the New York stock exchange (ENZ) is a growth-oriented integrated life sciences and biotechnology company focused on harnessing biological process to develop research tools, diagnostics and therapeutics, and serves as a provider of test services, including exotic tests, to the medical community. Since our founding in 1976, our strategic focus has been on the development of enabling technologies in the research, development, manufacture, licensing and marketing of innovative health care products, platforms and services based on molecular and cellular technologies.The business activities of Enzo Biochem, Inc. are performed by the company‘s three wholly owned subsidiaries; Enzo Life Sciences, Inc., Enzo Therapeutics, Inc., and Enzo Clinical Labs, Inc.

Enzo Life Sciences, Inc.

Enzo Life Sciences, Inc. is a wholly owned subsidiary of Enzo Biochem, Inc. headquartered in Farmingdale, New York.  The company is organized to lead in the development, production, marketing, and sales of innovative life science research reagents worldwide based on over 40 years of successful experience in building strong international market recognition, implementing outstanding operational capabilities, and establishing a state-of-the-art electronic information and ordering marketplace.

Enzo Life Sciences, Inc. is a recognized leader in labeling and detection technologies across research and diagnostic markets. Our strong portfolio of proteins, antibodies, peptides, small molecules, labeling probes dyes and kits provides life science researchers tools for target identification/validation,  high content analysis,  gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.

Now incorporating the skills, experience and products of ALEXIS® Biochemicals, acquired in 2007, BIOMOL® International, acquired in 2008, and ASSAY DESIGNS®  and STRESSGEN® acquired in 2009, the Enzo Life Sciences brand now provides 25 years of business experience in the supply of research kits, biochemicals and biologicals “Enabling Discovery in Life Science™”. Also acquired in 2007, Axxora, LLC operates as a separate entity to distribute other suppliers’ products worldwide, providing a product line that synergizes and fully complements the Enzo Life Sciences product line. Enzo Life Sciences is expanding its presence in the life science research market with the continual release of innovative kits and reagents to serve our core research areas, also offering custom fit-for-purpose assay development services to clients on a contract basis.

Featured Literature

ENZO Brochure

40 Years of Innovation

Pioneers in Labeling & Detection From Genome to Whole Cell

Enzo launches AMPIPROBE™ Candidiasis Assay

Enzo launches AMPIPROBE™ HCV RNA Assay

Enzo launches FLOWSCRIPT® HPV E6/E7 Assay

Enzo acquires assay designs® and Stressgen®

Enzo acquires Biomol® International

Enzo acquires Alexis® Biochemicals and AXXORA

Qiagen (Digene) offers most widely used HPV diagnostic test, relying on hybrid capture technology licensed from Enzo

Enzo launches PATHO-GENE® HPV detection

Enzo launches ISH probes for infectious diseases

Development of capture technology for the most widely-used clinical diagnostic test for HPV

Enzo offers full clinical services

Availability of nucleic acid arrays

Expansion of non-radioactive nucleic acid labeling technologies and availability of nonradioactive labeled nucleotides

Breakthrough technology for non-radioactive labeling and detection of nucleic acids developed

Enzo is incorporated

Recent acquisitions

2007 Alexis Corporation, Axxora LLC, and Apotech

ALEXIS Corporation was founded during 1993/1994 in Switzerland and the USA by a team of experts in the field of life science research reagents. Over the following years the company built a fast growing and comprehensive product line to serve the life science research market. Starting as an in-licensing, OEM and trading business, ALEXIS Corporation developed and acquired its own in-house manufacturing capabilities. By leveraging its own production with a series of proprietary product licensing arrangements with universities, research institutes, as well as biotech and biopharmaceutical companies, the brand ALEXIS® Biochemicals developed a strong reputation among researchers for providing the most innovative products within its chosen market segments.
In April 2005 ALEXIS® Biochemicals was enhanced by the merger with the Swiss company Apotech Corporation, a life science reagents company, discovering, developing and producing new products in the field of immunology, apoptosis, and inflammation.

2008 – Biomol International LP

Biomol International was formed by the merger of two leading companies in cellular biochemistry in 2004. Biomol Research Laboratories Inc., based in Plymouth Meeting, Pennsylvania, USA, was founded in 1983 focusing on the supply of innovative signal transduction reagents to the life science research market, while Affiniti Research Products Ltd., based in Exeter, UK, was founded in 1991 as a supplier of products and services to the neuroscience sector of the life science research market. The brand BIOMOL® International continued to serve the cellular biochemistry sector of the life science research market with innovative research products and services launching hundreds of new products every year.

2009 – Assay Designs Inc. and Stressgen Bioreagents

Founded in 1992 in Athens, Georgia then re-located to Ann Arbor, Michigan, Assay Designs® began as a small company with the goal of providing high quality, easy-to-use assay kits and highly characterized reagents to the life sciences research market. The portfolio of kits grew from the first PGE2 EIA kit to the present offering of over 200 assays for biomarkers relevant to inflammation and immunity, oxidative and cellular stress, steroid and hormone biology, cell signaling, and metabolism ELISA Kits. The Assay Designs acquisition of Stressgen Bioreagents in 2005 incorporated the definitive collection of Stressgen® brand antibodies, proteins, and kits for heat shock proteins, chaperones, and mediators of cellular stress to complement its product portfolio.

Business Structure

Today, Enzo Life Sciences offers over 8,000 products to the research community using a variety of marketing and sales channels. To serve our customers worldwide, we support the sales and distribution of our products directly through our global companies in USA, Germany, Switzerland, France, UK and Benelux and through a network partner companies who distribute products globally to over 50 additional countries.

Recommend this page

Keep in touch

©2022 Enzo Life Sciences, Inc.,